Radisens Diagnostics aims to revolutionize Point-of-Care Testing (PoCT) by providing comprehensive diagnostic solutions to bridge the existing diagnostic gaps. The company's innovative digital diagnostic device is designed to integrate immunochemistry, clinical chemistry, and hematology assays into multiplexed test panels, delivering instant results with just a drop of blood. Founded in 2009, Radisens Diagnostics received a significant €4.49M grant investment on 01 July 2015 from EASME - EU Executive Agency for SMEs, signaling a strong endorsement of its vision. The company's focus on chronic disease panels for diabetes, heart disease, hypertension, and chronic kidney conditions, with plans to expand into cell counting, cardiac, and oncology targets, positions it as a pioneer in empowering physicians with the tools to make informed diagnoses and enhance patient care. With the potential to drive significant cost savings and meet the performance-based incentives sought by insurers, Radisens Diagnostics presents an promising investment opportunity in the Health Care sector.
Radisens Diagnostics
Empowering physicians with instant, comprehensive point-of-care diagnostics to bridge diagnostic gaps and enhance patient care.
General Information
BounceWatch is an independent company data service, not affiliated with Radisens Diagnostics. To contact Radisens Diagnostics, visit radisens.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Radisens Diagnostics compare?
A PDF of Radisens Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Radisens Diagnostics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Radisens Diagnostics
Business keywords: Point-of-Care Testing, Diagnostic Devices, Chronic Disease Management, Medical Technology, Healthcare Efficiency, Physician Empowerment, Comprehensive Diagnostics, Digital Health, Patient Care, Healthcare Integration, Cost Savings, Clinical Chemistry, Hematology Assays, Chronic Disease Panels, Performance-Based Incentives
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | €4.49M | 1 |
EASME - EU Executive Agency for SMEs
|
01 Jul 2015 |
| Venture Round | €1.10M | 2 |
|
10 Jun 2011 |
Radisens Diagnostics Alternatives & Competitors
View All Alternatives
Point-of-Care Hematology
Empowering healthcare with innovative near-patient testing and diagnostic solutions since 2009.
Accel Diagnostics is a developer and manufacturer of blood diagnostic tests and laboratory analyzers...
FAQ About Radisens Diagnostics
Source: BounceWatch company record for Radisens Diagnostics, https://bouncewatch.com/company/radisens-diagnostics, updated 26 December 2024. When citing, please name BounceWatch and link this page.
